Main Properties Impacting Bioactivity of Calcium Phosphate Coatings: Comparison
View Latest Version
Please note this is a comparison between Version 4 by Sirius Huang and Version 3 by Richard Drevet.

The bioceramic coating properties are used to create a strong bonding between the bone implants and the surrounding bone tissue. They provide a fast response after implantation and increase the lifespan of the implant in the body environment. Key physicochemical properties of calcium phosphate coatings and their impact on the bioactivity and performance of bone implants in a physiological environment are presented herein.

  • biomaterials
  • coatings
  • calcium phosphates
  • hydroxyapatite
  • bone implant
  • biocompatibility
  • bioactivity

1. Calcium Phosphates

Calcium phosphate bioceramics are materials made of calcium ions (Ca2+) and phosphate ions (H2PO4−, HPO42−, or PO43−). Several compounds belong to this family, with different stoichiometries and different phosphate species. They are specifically identified in biomaterials science by their calcium-to-phosphorus atomic ratio (Ca/P)at. (Table 1).
Table 1.
Calcium phosphates described in the literature as coatings for bone implants.
(Ca/P)at. Calcium Phosphate Abbreviation Chemical Formulae Solubility

[-log K		s] References
2.00 tetracalcium phosphate TTCP Ca4(PO4)2O2 38.0–44.0 [55,56,57][1][2][3]
1.67 hydroxyapatite HAP Ca10(PO4)6OH2 116.8 [58,59,60][4][5][6]
1.50 α-tricalcium phosphate α-TCP α−Ca3(PO4)2 25.5 [61,62,63][7][8][9]
1.50 β-tricalcium phosphate β-TCP β−Ca3(PO4)2 28.9 [64,65,66][10][11][12]
1.34–1.66 calcium-deficient apatite Ca-def apatite Ca10−x(HPO4)x(PO4)6−x(OH)2−x

with 0 < x < 2		 85.1 [67,68,69][13][14][15]
1.33 octacalcium phosphate OCP Ca8(HPO4)2(PO4
[58].

2.3. Roughness

Bioactivity is a surface phenomenon influenced by, among other factors, the roughness of materials. High roughness exceeding 2 µm is not appropriate, because the long distances between valleys and peaks prevent the formation of the osteoblastic pseudopodia required for bone cell adhesion [189,190,191][59][60][61]. Calcium phosphate coatings with roughness values in the range of 0.5 to 1.5 μm are generally described to be the most interesting for the promotion of bone cell activity [192,193,194][62][63][64].

2.4. Porosity

The porosity of calcium phosphate coatings has a significant impact on the bioactive behavior of bone implants in a physiological environment. Pores larger than one hundred micrometers (macroporosity) support the growth of bone tissues through the coating and improve the connection between newly formed bone cells. However, these large pores also strongly reduce the mechanical properties of the bioceramic coatings [195][65]. Smaller pores of a few tens of micrometers and below (microporosity) enhance protein adsorption, body fluid circulation, and the resorption rate of the coating [196][66].

2.5. Wettability

Surface wettability is a key property of calcium phosphate coatings because the bioactivity processes occur in a liquid medium. Contact angle (θ) measurements are used to quantify the wetting behavior of a drop of physiological solution deposited on the coating surface [197,198,199][67][68][69]. As a function of the contact angle value, the surface is qualified as hydrophilic or hydrophobic.
Biomaterials with hydrophilic surfaces are more effective in promoting chemical and biological interactions with the physiological environment [201,202][70][71].

2.6. Adhesion

The adhesion of calcium phosphate coatings is the main mechanical property required by the biomedical market [104,203,204,205,206,207][72][73][74][75][76][77]. The value of coatings is determined by performing tensile adhesion measurements according to the international standard ISO 13779-4 [208][78].
The measurement requires a Ti6Al4V cylinder (25 mm in diameter and 25 mm in height) with one surface coated with calcium phosphate. The coated surface is attached to another Ti6Al4V cylinder by adhesive glue. The entire system is introduced into a standard tensile machine where an increasing load is applied until the separation of the coating is achieved by the breaking of the interface with the initially coated cylinder. A cohesive failure inside the coating may also occur, but in this case, the measurement is not valid and must be repeated. A minimum of five measurements of adhesive failure is necessary to obtain an average adhesion value. The bone implant industry requires adhesion values higher than 15 MPa [208][78].
This protocol is standardized for industrial applications, but several other methods can be used to determine the adhesion of calcium phosphate coatings, including the peel test, the scratch test, the ultrasonic test, and the laser shock adhesion test [104,209,210,211,212,213][72][79][80][81][82][83].

2.7. Ionic Substitution for Biological Enhancement

The bioactivity and biological properties of calcium phosphate coatings can be improved by means of ionic substitution [214,215,216,217,218,219,220,221,222,223][84][85][86][87][88][89][90][91][92][93]. The objective is to release the substituting ions in the physiological environment after implantation, taking advantage of the dissolution process (see Section 2)s. Several ionic substitutions have been described in the literature, using monovalent cations, divalent cations, trivalent cations, or anions. They are used to impart the various biological or chemical effects described in Table 2.
Table 2.
Ions used as substituents in calcium phosphate coatings.
Ions Biological/Chemical Effect References
monovalent cations    
Ag+ antibacterial activity [224,225,226][94][95][96]
K+ osteogenesis [227,228,229][97][98][99]
Li+ osteogenesis [230,231,232][100][101][102]
Na+ osteogenesis [233,234,235][103][104][105]
)4·5H2O 96.6 [70,71,72][16][17][18]
1.00 calcium pyrophosphate CPP Ca2P2O7 18.5 [73,74,75][19][20][21]
1.00 dicalcium phosphate anhydrous, also known as monetite DCPA CaHPO4 6.9 [76,77,78][22][23][24]
1.00 dicalcium phosphate dihydrate, also known as brushite DCPD CaHPO4·2H2O 6.6 [79,80,81][25][26][27]
0.50 monocalcium phosphate anhydrous MCPA Ca(H2PO4)2 1.1 [82,[83,2884]][29][30]
0.50 monocalcium phosphate monohydrate MCPM Ca(H2PO4)2·H2O 1.1 [85,86,87][31][32][33]
The stoichiometry of a calcium phosphate coating affects its solubility in a physiological environment, which is the first step involved in the bioactivity process after implantation.
The partial dissolution of the calcium phosphate coating in contact with the physiological environment induces ionic releases. The local concentrations of calcium and phosphate ions increase up to supersaturation, which triggers the precipitation of biological apatite at the interface between the implant and the surrounding bone tissues [30,31,35,36,37,38][34][35][36][37][38][39]. After these first chemical steps, the biological steps start, involving bone cell attachment, proliferation, and differentiation. In the last step of the bioactivity process, the bone cells trigger the formation of the extracellular matrix (ECM), which is a three-dimensional network of macromolecules and minerals, such as collagen, enzymes, glycoproteins, and apatite [88,89,90][40][41][42]. The function of the extracellular matrix is to provide structural and biochemical support to the surrounding bone cells to promote their development [91][43]. Due to the bioactivity of the calcium phosphate coatings, bone-like apatite is formed at the interface between the bone implant and the bone tissue. This bone-like apatite layer is a direct, adherent, and strong bonding that results in the long-term stability of the bone implant inside the human body [92][44]. However, the success of the bioactivity process is related to several properties of the calcium phosphate coating and not only to the stoichiometry and solubility of the bioceramic material. The choice of the process and the experimental deposition conditions may influence many physicochemical properties of the calcium phosphate coating, and consequently the bioactivity process.

2. Main Properties Impacting the Bioactivity of Calcium Phosphate Coatings

In addition to stoichiometry and solubility, several physicochemical properties impact the bioactivity of calcium phosphate coatings immersed in a physiological environment. Crystallinity, morphology, roughness, porosity, wettability, adhesion, and ionic substitution are the most important ones.

2.1. Crystallinity

The crystallinity of calcium phosphate coatings impacts their solubility in a physiological environment. The more crystallized the coating, the more stable it is in solution [175,176,177][45][46][47]. Crystallinity can be controlled by post-deposition thermal annealing. The international standard ISO 13779-2 recommends a degree of crystallinity higher than 45% for the biomedical market of bone implants [178][48]. However, as a function of the annealing temperature, several phases can form in addition to the calcium phosphate phases [179,180][49][50]. To maintain a low level of cytotoxicity, the quantity of secondary phases (for example CaO) in the calcium phosphate coatings should be below 5 wt.% [178][48]. The methods for determining the crystallinity of calcium phosphate coatings and the quantity of secondary phases are comprehensively described in the international standard ISO 13779-3 [181][51].

2.2. Morphology

The surface morphology of calcium phosphate coatings affects the bone cells’ attachment, growth, proliferation, and differentiation [182,183][52][53]. As a function of the deposition process and the experimental conditions, the surface morphology of the coatings can change [184,185][54][55]. Regular surface morphologies are more efficient for bone cell attachment than irregular and sharp ones [186][56]. According to Cairns et al., they significantly promote the expression of growth factors involved in bone formation in comparison with sharp surfaces made of needles [187,188][57]
divalent cations
 
 
Co2+ angiogenesis [236,237,238][106][107][108]
Cu2+ antibacterial activity [239,240,241][109][110][111]
Mg2+ osteogenesis [242,243,244][112][113][114]
Mn2+ osteogenesis [245,246,247][115][116][117]
Sr2+ osteogenesis [248,249,250,251][118][119][120][121]
Zn2+ osteogenesis/antibacterial/anti-inflammatory [252,253,254][122][123][124]
trivalent cations    
Bi3+ anticancer/antibacterial [255,256,257][125][126][127]
Ce3+ antibacterial [258,259,260,261][128][129][130][131]
Er3+ photoluminescence [262,[263,132264]][133][134]
Eu3+ osteogenesis/photoluminescence [265,266,267][135][136][137]
Fe3+ osteogenesis/anticancer/antibacterial [268,269,270][138][139][140]
Ga3+ anticancer/antibacterial [271,272,273][141][142][143]
Tb3+ photoluminescence [274,275][144][145]
anions    
Cl− osteogenesis [276,277,278][146][147][148]
CO32− osteogenesis [279,280,281][149][150][151]
F− antibacterial [282,283,284][152][153][154]
SeO32−/SeO42− anticancer/antibacterial [285,286,][155][156]287[157]
SiO44− osteogenesis [288,289,290][158][159][160]
A few percent of these ions are generally used to produce substituted calcium phosphate coatings. Multi-substitution with several substituting ions is also described in the literature with the objective of cumulating its positive effects on the biological properties of bone implants [291,292,293,294,295,296,297,298,299,300,301,302,303,304,305][161][162][163][164][165][166][167][168][169][170][171][172][173][174][175].

References

  1. Moseke, C.; Gbureck, U. Tetracalcium phosphate: Synthesis, properties and biomedical applications. Acta Biomater. 2010, 6, 3815–3823.
  2. Qin, T.; Xu, Y. Fe-reinforced TTCP biocermet prepared via laser melting: Microstructure, mechanical properties and bioactivity. Ceram. Int. 2021, 47, 17652–17661.
  3. Mandal, S.; Meininger, S.; Gbureck, U.; Basu, B. 3D powder printed tetracalcium phosphate scaffold with phytic acid binder: Fabrication, microstructure and in situ X-Ray tomography analysis of compressive failure. J. Mater. Sci. Mater. Med. 2018, 29, 29.
  4. LeGeros, R.Z. Properties of Osteoconductive Biomaterials: Calcium Phosphates. Clin. Orthop. Relat. Res. 2002, 395, 81–98.
  5. Hench, L.L. Bioceramics: From Concept to Clinic. J. Am. Ceram. Soc. 1991, 74, 1487–1510.
  6. Szcześ, A.; Hołysz, L.; Chibowski, E. Synthesis of hydroxyapatite for biomedical applications. Adv. Colloid Interface Sci. 2017, 249, 321–330.
  7. Carrodeguas, R.G.; De Aza, S. α-Tricalcium phosphate: Synthesis, properties and biomedical applications. Acta Biomater. 2011, 7, 3536–3546.
  8. De Aza, P.N.; Luklinska, Z.B.; de Val, J.E.M.-S.; Calvo-Guirado, J.L. Biodegradation Process of α-Tricalcium Phosphate and α-Tricalcium Phosphate Solid Solution Bioceramics In Vivo: A Comparative Study. Microsc. Microanal. 2013, 19, 1350–1357.
  9. Kolmas, J.; Kaflak, A.; Zima, A.; Ślósarczyk, A. Alpha-tricalcium phosphate synthesized by two different routes: Structural and spectroscopic characterization. Ceram. Int. 2015, 41, 5727–5733.
  10. Bohner, M.; Santoni, B.L.G.; Döbelin, N. β-tricalcium phosphate for bone substitution: Synthesis and properties. Acta Biomater. 2020, 113, 23–41.
  11. Chaair, H.; Labjar, H.; Britel, O. Synthesis of β-tricalcium phosphate. Morphologie 2017, 101, 120–124.
  12. Drevet, R.; Fauré, J.; Sayen, S.; Marle-Spiess, M.; El Btaouri, H.; Benhayoune, H. Electrodeposition of biphasic calcium phosphate coatings with improved dissolution properties. Mater. Chem. Phys. 2019, 236, 121797.
  13. Drouet, C. Apatite Formation: Why It May Not Work as Planned, and How to Conclusively Identify Apatite Compounds. BioMed Res. Int. 2013, 2013, 490946.
  14. Valletregi, M.; Rodriguez-Lorenzo, L. Synthesis and characterisation of calcium deficient apatite. Solid State Ion. 1997, 101–103, 1279–1285.
  15. Hutchens, S.A.; Benson, R.S.; Evans, B.R.; O’Neill, H.; Rawn, C.J. Biomimetic synthesis of calcium-deficient hydroxyapatite in a natural hydrogel. Biomaterials 2006, 27, 4661–4670.
  16. Teterina, A.Y.; Smirnov, I.V.; Fadeeva, I.S.; Fadeev, R.S.; Smirnova, P.V.; Minaychev, V.V.; Kobyakova, M.I.; Fedotov, A.Y.; Barinov, S.M.; Komlev, V.S. Octacalcium Phosphate for Bone Tissue Engineering: Synthesis, Modification, and In Vitro Biocompatibility Assessment. Int. J. Mol. Sci. 2021, 22, 12747.
  17. Suzuki, O.; Hamai, R.; Sakai, S. The material design of octacalcium phosphate bone substitute: Increased dissolution and osteogenecity. Acta Biomater. 2023, 158, 1–11.
  18. Kovrlija, I.; Locs, J.; Loca, D. Octacalcium phosphate: Innovative vehicle for the local biologically active substance delivery in bone regeneration. Acta Biomater. 2021, 135, 27–47.
  19. Vasant, S.R.; Joshi, M.J. A review on calcium pyrophosphate and other related phosphate nano bio-materials and their applications. Rev. Adv. Mater. Sci. 2017, 49, 44–57.
  20. Yan, Y.; Wolke, J.; De Ruijter, A.; Yubao, L.; Jansen, J. Growth behavior of rat bone marrow cells on RF magnetron sputtered hydroxyapatite and dicalcium pyrophosphate coatings. J. Biomed. Mater. Res. Part A 2006, 78A, 42–49.
  21. Golubchikov, D.; Safronova, T.V.; Nemygina, E.; Shatalova, T.B.; Tikhomirova, I.N.; Roslyakov, I.V.; Khayrutdinova, D.; Platonov, V.; Boytsova, O.; Kaimonov, M.; et al. Powder Synthesized from Aqueous Solution of Calcium Nitrate and Mixed-Anionic Solution of Orthophosphate and Silicate Anions for Bioceramics Production. Coatings 2023, 13, 374.
  22. Zhou, H.; Yang, L.; Gbureck, U.; Bhaduri, S.B.; Sikder, P. an important calcium phosphate compound–Its synthesis, properties and applications in orthopedics. Acta Biomater. 2021, 127, 41–55.
  23. da Silva, M.P.; Lima, J.; Soares, G.; Elias, C.; de Andrade, M.; Best, S.; Gibson, I. Transformation of monetite to hydroxyapatite in bioactive coatings on titanium. Surf. Coat. Technol. 2001, 137, 270–276.
  24. Ling, L.; Xin-Bo, X.; Jun, M.; Xin-Ye, N.; Xie-Rong, Z.; Sial, M.A.Z.G.; Dazhu, C. Post-hydrothermal treatment of hydrothermal electrodeposited CaHPO4 on C/C composites in sodium silicate-containing solution at various temperatures. Ceram. Int. 2018, 45, 5894–5903.
  25. Tamimi, F.; Sheikh, Z.; Barralet, J. Dicalcium phosphate cements: Brushite and monetite. Acta Biomater. 2012, 8, 474–487.
  26. Türk, S.; Altınsoy, I.; Çelebiefe, G.; Ipek, M.; Özacar, M.; Bindal, C. Biomimetric coating of monophasic brushite on Ti6Al4V in new m-5xSBF. Surf. Coat. Technol. 2018, 351, 1–10.
  27. Lee, D.-W.; Shin, M.-C.; Kim, Y.-N.; Oh, J.-M. Brushite ceramic coatings for dental brace brackets fabricated via aerosol deposition. Ceram. Int. 2017, 43, 1044–1051.
  28. Su, Y.; Cockerill, I.; Zheng, Y.; Tang, L.; Qin, Y.-X.; Zhu, D. Biofunctionalization of metallic implants by calcium phosphate coatings. Bioact. Mater. 2019, 4, 196–206.
  29. Eliaz, N.; Metoki, N. Calcium Phosphate Bioceramics: A Review of Their History, Structure, Properties, Coating Technologies and Biomedical Applications. Materials 2017, 10, 334.
  30. Dorozhkin, S.V. Calcium orthophosphates (CaPO4): Occurrence and properties. Prog. Biomater. 2015, 5, 9–70.
  31. Huan, Z.; Chang, J. Novel bioactive composite bone cements based on the β-tricalcium phosphate–monocalcium phosphate monohydrate composite cement system. Acta Biomater. 2008, 5, 1253–1264.
  32. Dorozhkin, S.V. A detailed history of calcium orthophosphates from 1770s till 1950. Mater. Sci. Eng. C 2013, 33, 3085–3110.
  33. Bermúdez, O.; Boltong, M.G.; Driessens, F.C.M.; Planell, J.A. Optimization of a calcium orthophosphate cement formulation occurring in the combination of monocalcium phosphate monohydrate with calcium oxide. J. Mater. Sci. Mater. Med. 1994, 5, 67–71.
  34. Williams, D. Revisiting the definition of biocompatibility. Med. Device Technol. 2003, 14, 10–13.
  35. Williams, D.F. On the mechanisms of biocompatibility. Biomaterials 2008, 29, 2941–2953.
  36. Williams, D.F. Biocompatibility pathways and mechanisms for bioactive materials: The bioactivity zone. Bioact. Mater. 2021, 10, 306–322.
  37. Williams, D.F. On the nature of biomaterials. Biomaterials 2009, 30, 5897–5909.
  38. Cao, W.; Hench, L.L. Bioactive materials. Ceram. Int. 1996, 22, 493–507.
  39. Albrektsson, T.; Johansson, C. Osteoinduction, osteoconduction and osseointegration. Eur. Spine J. 2001, 10, S96–S101.
  40. Ducheyne, P.; Qiu, Q. Bioactive ceramics: The effect of surface reactivity on bone formation and bone cell function. Biomaterials 1999, 20, 2287–2303.
  41. Kokubo, T.; Takadama, H. How useful is SBF in predicting in vivo bone bioactivity? Biomaterials 2006, 27, 2907–2915.
  42. Hoppe, A.; Güldal, N.S.; Boccaccini, A.R. A review of the biological response to ionic dissolution products from bioactive glasses and glass-ceramics. Biomaterials 2011, 32, 2757–2774.
  43. Bohner, M.; Lemaitre, J. Can bioactivity be tested in vitro with SBF solution? Biomaterials 2009, 30, 2175–2179.
  44. Ho-Shui-Ling, A.; Bolander, J.; Rustom, L.E.; Johnson, A.W.; Luyten, F.P.; Picart, C. Bone regeneration strategies: Engineered scaffolds, bioactive molecules and stem cells current stage and future perspectives. Biomaterials 2018, 180, 143–162.
  45. Degli Esposti, L.; Markovic, S.; Ignjatovic, N.; Panseri, S.; Montesi, M.; Adamiano, A.; Fosca, M.; Rau, J.V.; Uskoković, V.; Iafisco, M. Thermal crystallization of amorphous calcium phosphate combined with citrate and fluoride doping: A novel route to produce hydroxyapatite bioceramics. J. Mater. Chem. B 2021, 9, 4832–4845.
  46. Gerk, S.A.; Golovanova, O.A.; Odazhiu, V.N. Structural, Morphological, and Resorption Properties of Carbonate Hydroxyapatite Prepared in the Presence of Glycine. Inorg. Mater. 2018, 54, 305–314.
  47. Hu, Q.; Tan, Z.; Liu, Y.; Tao, J.; Cai, Y.; Zhang, M.; Pan, H.; Xu, X.; Tang, R. Effect of crystallinity of calcium phosphate nanoparticles on adhesion, proliferation, and differentiation of bone marrow mesenchymal stem cells. J. Mater. Chem. 2007, 17, 4690–4698.
  48. ISO 13779-2; Implants for Surgery—Hydroxyapatite—Part 2: Thermally Sprayed Coatings of Hydroxyapatite. International Organization for Standardization: Geneva, Switzerland, 2018.
  49. Raynaud, S.; Champion, E.; Bernache-Assollant, D. Calcium phosphate apatites with variable Ca/P atomic ratio II. Calcination and sintering. Biomaterials 2001, 23, 1073–1080.
  50. Destainville, A.; Champion, E.; Bernache-Assollant, D.; Laborde, E. Synthesis, characterization and thermal behavior of apatitic tricalcium phosphate. Mater. Chem. Phys. 2003, 80, 269–277.
  51. ISO 13779-3; Implants for Surgery—Hydroxyapatite—Part 3: Analyse Chimique et Caractérisation du Rapport de Cristallinité et de la Pureté de Phase. International Organization for Standardization: Geneva, Switzerland, 2018.
  52. Katić, J.; Krivačić, S.; Petrović, Ž.; Mikić, D.; Marciuš, M. Titanium Implant Alloy Modified by Electrochemically Deposited Functional Bioactive Calcium Phosphate Coatings. Coatings 2023, 13, 640.
  53. Iwamoto, T.; Hieda, Y.; Kogai, Y. Effect of hydroxyapatite surface morphology on cell adhesion. Mater. Sci. Eng. C 2016, 69, 1263–1267.
  54. Drevet, R.; Fauré, J.; Benhayoune, H. Structural and morphological study of electrodeposited calcium phosphate materials submitted to thermal treatment. Mater. Lett. 2017, 209, 27–31.
  55. Liu, S.; Li, H.; Zhang, L.; Yin, X.; Guo, Y. In simulated body fluid performance of polymorphic apatite coatings synthesized by pulsed electrodeposition. Mater. Sci. Eng. C 2017, 79, 100–107.
  56. Lee, W.-K.; Lee, S.-M.; Kim, H.-M. Effect of surface morphology of calcium phosphate on osteoblast-like HOS cell responses. J. Ind. Eng. Chem. 2009, 15, 677–682.
  57. Cairns, M.; Meenan, B.; Burke, G.; Boyd, A. Influence of surface topography on osteoblast response to fibronectin coated calcium phosphate thin films. Colloids Surf. B Biointerfaces 2010, 78, 283–290.
  58. Pujari-Palmer, S.; Chen, S.; Rubino, S.; Weng, H.; Xia, W.; Engqvist, H.; Tang, L.; Ott, M.K. In vivo and in vitro evaluation of hydroxyapatite nanoparticle morphology on the acute inflammatory response. Biomaterials 2016, 90, 1–11.
  59. Chen, S.; Guo, Y.; Liu, R.; Wu, S.; Fang, J.; Huang, B.; Li, Z.; Chen, Z.; Chen, Z. Tuning surface properties of bone biomaterials to manipulate osteoblastic cell adhesion and the signaling pathways for the enhancement of early osseointegration. Colloids Surf. B Biointerfaces 2018, 164, 58–69.
  60. Khlusov, I.A.; Dekhtyar, Y.; Sharkeev, Y.P.; Pichugin, V.F.; Khlusova, M.Y.; Polyaka, N.; Tyulkin, F.; Vendinya, V.; Legostaeva, E.V.; Litvinova, L.S.; et al. Nanoscale Electrical Potential and Roughness of a Calcium Phosphate Surface Promotes the Osteogenic Phenotype of Stromal Cells. Materials 2018, 11, 978.
  61. Deligianni, D.D.; Katsala, N.D.; Koutsoukos, P.G.; Missirlis, Y.F. Effect of surface roughness of hydroxyapatite on human bone marrow cell adhesion, proliferation, differentiation and detachment strength. Biomaterials 2000, 22, 87–96.
  62. Anselme, K.; Bigerelle, M. On the relation between surface roughness of metallic substrates and adhesion of human primary bone cells. Scanning 2012, 36, 11–20.
  63. Giljean, S.; Bigerelle, M.; Anselme, K. Roughness statistical influence on cell adhesion using profilometry and multiscale analysis. Scanning 2012, 36, 2–10.
  64. Adeleke, S.; Ramesh, S.; Bushroa, A.; Ching, Y.; Sopyan, I.; Maleque, M.; Krishnasamy, S.; Chandran, H.; Misran, H.; Sutharsini, U. The properties of hydroxyapatite ceramic coatings produced by plasma electrolytic oxidation. Ceram. Int. 2018, 44, 1802–1811.
  65. Pecqueux, F.; Tancret, F.; Payraudeau, N.; Bouler, J. Influence of microporosity and macroporosity on the mechanical properties of biphasic calcium phosphate bioceramics: Modelling and experiment. J. Eur. Ceram. Soc. 2010, 30, 819–829.
  66. Miao, X.; Hu, Y.; Liu, J.; Wong, A. Porous calcium phosphate ceramics prepared by coating polyurethane foams with calcium phosphate cements. Mater. Lett. 2004, 58, 397–402.
  67. Maidaniuc, A.; Miculescu, F.; Voicu, S.I.; Andronescu, C.; Miculescu, M.; Matei, E.; Mocanu, A.C.; Pencea, I.; Csaki, I.; Machedon-Pisu, T.; et al. Induced wettability and surface-volume correlation of composition for bovine bone derived hydroxyapatite particles. Appl. Surf. Sci. 2018, 438, 158–166.
  68. Paital, S.R.; Dahotre, N.B. Wettability and kinetics of hydroxyapatite precipitation on a laser-textured Ca–P bioceramic coating. Acta Biomater. 2009, 5, 2763–2772.
  69. Bodhak, S.; Bose, S.; Bandyopadhyay, A. Role of surface charge and wettability on early stage mineralization and bone cell–materials interactions of polarized hydroxyapatite. Acta Biomater. 2009, 5, 2178–2188.
  70. Thian, E.S.; Ahmad, Z.; Huang, J.; Edirisinghe, M.J.; Jayasinghe, S.N.; Ireland, D.C.; Brooks, R.A.; Rushton, N.; Bonfield, W.; Best, S.M. The role of surface wettability and surface charge of electrosprayed nanoapatites on the behaviour of osteoblasts. Acta Biomater. 2010, 6, 750–755.
  71. Aronov, D.; Rosen, R.; Ron, E.; Rosenman, G. Tunable hydroxyapatite wettability: Effect on adhesion of biological molecules. Process. Biochem. 2006, 41, 2367–2372.
  72. Mohseni, E.; Zalnezhad, E.; Bushroa, A. Comparative investigation on the adhesion of hydroxyapatite coating on Ti–6Al–4V implant: A review paper. Int. J. Adhes. Adhes. 2014, 48, 238–257.
  73. Fornell, J.; Feng, Y.; Pellicer, E.; Suriñach, S.; Baró, M.; Sort, J. Mechanical behaviour of brushite and hydroxyapatite coatings electrodeposited on newly developed FeMnSiPd alloys. J. Alloys Compd. 2017, 729, 231–239.
  74. Fathyunes, L.; Khalil-Allafi, J.; Moosavifar, M. Development of graphene oxide/calcium phosphate coating by pulse electrodeposition on anodized titanium: Biocorrosion and mechanical behavior. J. Mech. Behav. Biomed. Mater. 2018, 90, 575–586.
  75. Singh, S.; Prakash, C.; Singh, H. Deposition of HA-TiO2 by plasma spray on β-phase Ti-35Nb-7Ta-5Zr alloy for hip stem: Characterization, mechanical properties, corrosion, and in-vitro bioactivity. Surf. Coat. Technol. 2020, 398, 126072.
  76. Drevet, R.; Fauré, J.; Benhayoune, H. Thermal Treatment Optimization of Electrodeposited Hydroxyapatite Coatings on Ti6Al4V Substrate. Adv. Eng. Mater. 2012, 14, 377–382.
  77. Harun, W.; Asri, R.; Alias, J.; Zulkifli, F.; Kadirgama, K.; Ghani, S.; Shariffuddin, J. A comprehensive review of hydroxyapatite-based coatings adhesion on metallic biomaterials. Ceram. Int. 2018, 44, 1250–1268.
  78. ISO 13779-4; Implants for Surgery—Hydroxyapatite—Part 4: Determination of Coating Adhesion Strength. International Organization for Standardization: Geneva, Switzerland, 2018.
  79. Lei, W.-S.; Mittal, K.; Yu, Z. Adhesion Measurement of Coatings on Biodevices/Implants: A Critical Review. Rev. Adhes. Adhes. 2016, 4, 367–397.
  80. Kurzweg, H.; Heimann, R.B.; Troczynski, T. Adhesion of thermally sprayed hydroxyapatite–bond-coat systems measured by a novel peel test. J. Mater. Sci. Mater. Med. 1998, 9, 9–16.
  81. Barnes, D.; Johnson, S.; Snell, R.; Best, S. Using scratch testing to measure the adhesion strength of calcium phosphate coatings applied to poly(carbonate urethane) substrates. J. Mech. Behav. Biomed. Mater. 2011, 6, 128–138.
  82. Hsu, H.-C.; Wu, S.-C.; Lin, C.-Y.; Ho, W.-F. Characterization of Hydroxyapatite/Chitosan Composite Coating Obtained from Crab Shells on Low-Modulus Ti–25Nb–8Sn Alloy through Hydrothermal Treatment. Coatings 2023, 13, 228.
  83. Guipont, V.; Jeandin, M.; Bansard, S.; Khor, K.A.; Nivard, M.; Berthe, L.; Cuq-Lelandais, J.-P.; Boustie, M. Bond strength determination of hydroxyapatite coatings on Ti-6Al-4V substrates using the LAser Shock Adhesion Test (LASAT). J. Biomed. Mater. Res. Part A 2010, 95A, 1096–1104.
  84. Uskoković, V. Ion-doped hydroxyapatite: An impasse or the road to follow? Ceram. Int. 2020, 46, 11443–11465.
  85. Furko, M.; Balázsi, C. Morphological, Chemical, and Biological Investigation of Ionic Substituted, Pulse Current Deposited Calcium Phosphate Coatings. Materials 2020, 13, 4690.
  86. Ungureanu, E.; Vranceanu, D.M.; Vladescu, A.; Parau, A.C.; Tarcolea, M.; Cotrut, C.M. Effect of Doping Element and Electrolyte’s pH on the Properties of Hydroxyapatite Coatings Obtained by Pulsed Galvanostatic Technique. Coatings 2021, 11, 1522.
  87. Panda, S.; Biswas, C.K.; Paul, S. A comprehensive review on the preparation and application of calcium hydroxyapatite: A special focus on atomic doping methods for bone tissue engineering. Ceram. Int. 2021, 47, 28122–28144.
  88. Schatkoski, V.M.; do Amaral Montanheiro, T.L.; de Menezes, B.R.C.; Pereira, R.M.; Rodrigues, K.F.; Ribas, R.G.; da Silva, D.M.; Thim, G.P. Current advances concerning the most cited metal ions doped bioceramics and silicate-based bioactive glasses for bone tissue engineering. Ceram. Int. 2021, 47, 2999–3012.
  89. Boanini, E.; Gazzano, M.; Bigi, A. Ionic substitutions in calcium phosphates synthesized at low temperature. Acta Biomater. 2010, 6, 1882–1894.
  90. Bigi, A.; Boanini, E.; Gazzano, M. Ion substitution in biological and synthetic apatites. In Biomineralization and Biomaterials, Fundamentals and Applications, 1st ed.; Aparicio, C., Ginebra, M.P., Eds.; Woodhead Publishing (Elsevier): Sawston, UK, 2015; pp. 235–266. ISBN 9781782423386.
  91. Wang, W.; Yeung, K.W.K. Bone grafts and biomaterials substitutes for bone defect repair: A review. Bioact. Mater. 2017, 2, 224–247.
  92. Arcos, D.; Vallet-Regí, M. Substituted hydroxyapatite coatings of bone implants. J. Mater. Chem. B 2020, 8, 1781–1800.
  93. Ratnayake, J.T.B.; Mucalo, M.; Dias, G.J. Substituted hydroxyapatites for bone regeneration: A review of current trends. J. Biomed. Mater. Res. Part B Appl. Biomater. 2016, 105, 1285–1299.
  94. Dubnika, A.; Loca, D.; Rudovica, V.; Parekh, M.B.; Berzina-Cimdina, L. Functionalized silver doped hydroxyapatite scaffolds for controlled simultaneous silver ion and drug delivery. Ceram. Int. 2017, 43, 3698–3705.
  95. Chen, K.; Ustriyana, P.; Moore, F.; Sahai, N. Biological Response of and Blood Plasma Protein Adsorption on Silver-Doped Hydroxyapatite. ACS Biomater. Sci. Eng. 2019, 5, 561–571.
  96. Mokabber, T.; Cao, H.; Norouzi, N.; Van Rijn, P.; Pei, Y. Antimicrobial Electrodeposited Silver-Containing Calcium Phosphate Coatings. ACS Appl. Mater. Interfaces 2020, 12, 5531–5541.
  97. Wiesmann, H.-P.; Plate, U.; Zierold, K.; Hohling, H.J. Potassium is Involved in Apatite Biomineralization. J. Dent. Res. 1998, 77, 1654–1657.
  98. Kannan, S.; Ventura, J.; Ferreira, J. Synthesis and thermal stability of potassium substituted hydroxyapatites and hydroxyapatite/β-tricalciumphosphate mixtures. Ceram. Int. 2007, 33, 1489–1494.
  99. Kumar, M.; Xie, J.; Chittur, K.; Riley, C. Transformation of modified brushite to hydroxyapatite in aqueous solution: Effects of potassium substitution. Biomaterials 1999, 20, 1389–1399.
  100. Kaygili, O.; Keser, S.; Ates, T.; Yakuphanoglu, F. Synthesis and characterization of lithium calcium phosphate ceramics. Ceram. Int. 2013, 39, 7779–7785.
  101. Pan, C.; Chen, L.; Wu, R.; Shan, H.; Zhou, Z.; Lin, Y.; Yu, X.; Yan, L.; Wu, C. Lithium-containing biomaterials inhibit osteoclastogenesis of macrophages in vitro and osteolysis in vivo. J. Mater. Chem. B 2018, 6, 8115–8126.
  102. Wang, Y.; Yang, X.; Gu, Z.; Qin, H.; Li, L.; Liu, J.; Yu, X. In vitro study on the degradation of lithium-doped hydroxyapatite for bone tissue engineering scaffold. Mater. Sci. Eng. C 2016, 66, 185–192.
  103. Li, H.; Zhao, X.; Cao, S.; Li, K.; Chen, M.; Xu, Z.; Lu, J.; Zhang, L. Na-doped hydroxyapatite coating on carbon/carbon composites: Preparation, in vitro bioactivity and biocompatibility. Appl. Surf. Sci. 2012, 263, 163–173.
  104. Kannan, S.; Ventura, J.M.G.; Lemos, A.F.; Barba, A.; Ferreira, J.M.F. Effect of sodium addition on the preparation of hydroxyapatites and biphasic ceramics. Ceram. Int. 2008, 34, 7–13.
  105. Cho, J.S.; Um, S.-H.; Yoo, D.S.; Chung, Y.-C.; Chung, S.H.; Lee, J.-C.; Rhee, S.-H. Enhanced osteoconductivity of sodium-substituted hydroxyapatite by system instability. J. Biomed. Mater. Res. Part B Appl. Biomater. 2013, 102, 1046–1062.
  106. Tang, C.-M.; Fan, F.-Y.; Ke, Y.-C.; Lin, W.-C. Effects of electrode plate annealing treatment and the addition of hydrogen peroxide on improving the degradation of cobalt hydroxyapatite for bone repair. Mater. Chem. Phys. 2020, 259, 123962.
  107. Lin, W.-C.; Chuang, C.-C.; Wang, P.-T.; Tang, C.-M. A Comparative Study on the Direct and Pulsed Current Electrodeposition of Cobalt-Substituted Hydroxyapatite for Magnetic Resonance Imaging Application. Materials 2018, 12, 116.
  108. Drevet, R.; Zhukova, Y.; Dubinskiy, S.; Kazakbiev, A.; Naumenko, V.; Abakumov, M.; Fauré, J.; Benhayoune, H.; Prokoshkin, S. Electrodeposition of cobalt-substituted calcium phosphate coatings on Ti22Nb6Zr alloy for bone implant applications. J. Alloys Compd. 2019, 793, 576–582.
  109. Grass, G.; Rensing, C.; Solioz, M. Metallic Copper as an Antimicrobial Surface. Appl. Environ. Microbiol. 2011, 77, 1541–1547.
  110. Wolf-Brandstetter, C.; Oswald, S.; Bierbaum, S.; Wiesmann, H.-P.; Scharnweber, D. Influence of pulse ratio on codeposition of copper species with calcium phosphate coatings on titanium by means of electrochemically assisted deposition. J. Biomed. Mater. Res. Part B Appl. Biomater. 2013, 102, 160–172.
  111. Prosolov, K.A.; Lastovka, V.V.; Khimich, M.A.; Chebodaeva, V.V.; Khlusov, I.A.; Sharkeev, Y.P. RF Magnetron Sputtering of Substituted Hydroxyapatite for Deposition of Biocoatings. Materials 2022, 15, 6828.
  112. Farzadi, A.; Bakhshi, F.; Solati-Hashjin, M.; Asadi-Eydivand, M.; abu Osman, N.A. Magnesium incorporated hydroxyapatite: Synthesis and structural properties characterization. Ceram. Int. 2014, 40, 6021–6029.
  113. Cacciotti, I.; Bianco, A.; Lombardi, M.; Montanaro, L. Mg-substituted hydroxyapatite nanopowders: Synthesis, thermal stability and sintering behaviour. J. Eur. Ceram. Soc. 2009, 29, 2969–2978.
  114. Vranceanu, D.M.; Ionescu, I.C.; Ungureanu, E.; Cojocaru, M.O.; Vladescu, A.; Cotrut, C.M. Magnesium Doped Hydroxyapatite-Based Coatings Obtained by Pulsed Galvanostatic Electrochemical Deposition with Adjustable Electrochemical Behavior. Coatings 2020, 10, 727.
  115. Huang, Y.; Qiao, H.; Nian, X.; Zhang, X.; Zhang, X.; Song, G.; Xu, Z.; Zhang, H.; Han, S. Improving the bioactivity and corrosion resistance properties of electrodeposited hydroxyapatite coating by dual doping of bivalent strontium and manganese ion. Surf. Coat. Technol. 2016, 291, 205–215.
  116. Huang, Y.; Ding, Q.; Han, S.; Yan, Y.; Pang, X. Characterisation, corrosion resistance and in vitro bioactivity of manganese-doped hydroxyapatite films electrodeposited on titanium. J. Mater. Sci. Mater. Med. 2013, 24, 1853–1864.
  117. Fadeeva, I.V.; Kalita, V.I.; Komlev, D.I.; Radiuk, A.A.; Fomin, A.S.; Davidova, G.A.; Fursova, N.K.; Murzakhanov, F.F.; Gafurov, M.R.; Fosca, M.; et al. In Vitro Properties of Manganese-Substituted Tricalcium Phosphate Coatings for Titanium Biomedical Implants Deposited by Arc Plasma. Materials 2020, 13, 4411.
  118. Pilmane, M.; Salma-Ancane, K.; Loca, D.; Locs, J.; Berzina-Cimdina, L. Strontium and strontium ranelate: Historical review of some of their functions. Mater. Sci. Eng. C 2017, 78, 1222–1230.
  119. Boanini, E.; Torricelli, P.; Fini, M.; Bigi, A. Osteopenic bone cell response to strontium-substituted hydroxyapatite. J. Mater. Sci. Mater. Med. 2011, 22, 2079–2088.
  120. Drevet, R.; Benhayoune, H. Pulsed electrodeposition for the synthesis of strontium-substituted calcium phosphate coatings with improved dissolution properties. Mater. Sci. Eng. C 2013, 33, 4260–4265.
  121. Capuccini, C.; Torricelli, P.; Sima, F.; Boanini, E.; Ristoscu, C.; Bracci, B.; Socol, G.; Fini, M.; Mihailescu, I.; Bigi, A. Strontium-substituted hydroxyapatite coatings synthesized by pulsed-laser deposition: In vitro osteoblast and osteoclast response. Acta Biomater. 2008, 4, 1885–1893.
  122. Tang, Y.; Chappell, H.F.; Dove, M.T.; Reeder, R.J.; Lee, Y.J. Zinc incorporation into hydroxylapatite. Biomaterials 2009, 30, 2864–2872.
  123. Huang, Y.; Zhang, X.; Mao, H.; Li, T.; Zhao, R.; Yan, Y.; Pang, X. Osteoblastic cell responses and antibacterial efficacy of Cu/Zn co-substituted hydroxyapatite coatings on pure titanium using electrodeposition method. RSC Adv. 2015, 5, 17076–17086.
  124. Furko, M.; Jiang, Y.; Wilkins, T.; Balázsi, C. Development and characterization of silver and zinc doped bioceramic layer on metallic implant materials for orthopedic application. Ceram. Int. 2016, 42, 4924–4931.
  125. El Khouri, A.; Zegzouti, A.; Elaatmani, M.; Capitelli, F. Bismuth-substituted hydroxyapatite ceramics synthesis: Morphological, structural, vibrational and dielectric properties. Inorg. Chem. Commun. 2019, 110, 107568.
  126. Ciobanu, G.; Bargan, A.M.; Luca, C. New Bismuth-Substituted Hydroxyapatite Nanoparticles for Bone Tissue Engineering. JOM 2015, 67, 2534–2542.
  127. Ahmed, M.K.; Mansour, S.F.; Mostafa, M.S.; Darwesh, R.; El-Dek, S.I. Structural, mechanical and thermal features of Bi and Sr co-substituted hydroxyapatite. J. Mater. Sci. 2018, 54, 1977–1991.
  128. Lin, Y.; Yang, Z.; Cheng, J. Preparation, Characterization and Antibacterial Property of Cerium Substituted Hydroxyapatite Nanoparticles. J. Rare Earths 2007, 25, 452–456.
  129. Feng, Z.; Liao, Y.; Ye, M. Synthesis and structure of cerium-substituted hydroxyapatite. J. Mater. Sci. Mater. Med. 2005, 16, 417–421.
  130. Ciobanu, G.; Harja, M. Cerium-doped hydroxyapatite/collagen coatings on titanium for bone implants. Ceram. Int. 2018, 45, 2852–2857.
  131. Nisar, A.; Iqbal, S.; Rehman, M.A.U.; Mahmood, A.; Younas, M.; Hussain, S.Z.; Tayyaba, Q.; Shah, A. Study of physico-mechanical and electrical properties of cerium doped hydroxyapatite for biomedical applications. Mater. Chem. Phys. 2023, 299, 127511.
  132. Alshemary, A.Z.; Akram, M.; Goh, Y.-F.; Kadir, M.R.A.; Abdolahi, A.; Hussain, R. Structural characterization, optical properties and in vitro bioactivity of mesoporous erbium-doped hydroxyapatite. J. Alloys Compd. 2015, 645, 478–486.
  133. Neacsu, I.A.; Stoica, A.E.; Vasile, B.S.; Andronescu, E. Luminescent Hydroxyapatite Doped with Rare Earth Elements for Biomedical Applications. Nanomaterials 2019, 9, 239.
  134. Pham, V.-H.; Van, H.N.; Tam, P.D.; Ha, H.N.T. A novel 1540nm light emission from erbium doped hydroxyapatite/β-tricalcium phosphate through co-precipitation method. Mater. Lett. 2016, 167, 145–147.
  135. Yang, P.; Quan, Z.; Li, C.; Kang, X.; Lian, H.; Lin, J. Bioactive, luminescent and mesoporous europium-doped hydroxyapatite as a drug carrier. Biomaterials 2008, 29, 4341–4347.
  136. Al-Kattan, A.; Santran, V.; Dufour, P.; Dexpert-Ghys, J.; Drouet, C. Novel contributions on luminescent apatite-based colloids intended for medical imaging. J. Biomater. Appl. 2013, 28, 697–707.
  137. Graeve, O.A.; Kanakala, R.; Madadi, A.; Williams, B.C.; Glass, K.C. Luminescence variations in hydroxyapatites doped with Eu2+ and Eu3+ ions. Biomaterials 2010, 31, 4259–4267.
  138. Singh, R.K.; Srivastava, M.; Prasad, N.; Awasthi, S.; Dhayalan, A.; Kannan, S. Iron doped β-Tricalcium phosphate: Synthesis, characterization, hyperthermia effect, biocompatibility and mechanical evaluation. Mater. Sci. Eng. C 2017, 78, 715–726.
  139. Singh, R.K.; Srivastava, M.; Prasad, N.K.; Shetty, P.H.; Kannan, S. Hyperthermia effect and antibacterial efficacy of Fe3+/Co2+ co-substitutions in β-Ca3(PO4)2 for bone cancer and defect therapy. J. Biomed. Mater. Res. Part B Appl. Biomater. 2017, 106, 1317–1328.
  140. Predoi, D.; Iconaru, S.L.; Ciobanu, S.C.; Predoi, S.-A.; Buton, N.; Megier, C.; Beuran, M. Development of Iron-Doped Hydroxyapatite Coatings. Coatings 2021, 11, 186.
  141. Melnikov, P.; Teixeira, A.; Malzac, A.; Coelho, M.D.B. Gallium-containing hydroxyapatite for potential use in orthopedics. Mater. Chem. Phys. 2009, 117, 86–90.
  142. Korbas, M.; Rokita, E.; Meyer-Klaucke, W.; Ryczek, J. Bone tissue incorporates in vitro gallium with a local structure similar to gallium-doped brushite. JBIC J. Biol. Inorg. Chem. 2003, 9, 67–76.
  143. Mosina, M.; Siverino, C.; Stipniece, L.; Sceglovs, A.; Vasiljevs, R.; Moriarty, T.F.; Locs, J. Gallium-Doped Hydroxyapatite Shows Antibacterial Activity against Pseudomonas aeruginosa without Affecting Cell Metabolic Activity. J. Funct. Biomater. 2023, 14, 51.
  144. Paduraru, A.V.; Oprea, O.; Musuc, A.M.; Vasile, B.S.; Iordache, F.; Andronescu, E. Influence of Terbium Ions and Their Concentration on the Photoluminescence Properties of Hydroxyapatite for Biomedical Applications. Nanomaterials 2021, 11, 2442.
  145. Jiménez-Flores, Y.; Suárez-Quezada, M.; Rojas-Trigos, J.B.; Lartundo-Rojas, L.; Suarez, M.; Mantilla, A. Characterization of Tb-doped hydroxyapatite for biomedical applications: Optical properties and energy band gap determination. J. Mater. Sci. 2017, 52, 9990–10000.
  146. Demnati, I.; Grossin, D.; Combes, C.; Parco, M.; Braceras, I.; Rey, C. A comparative physico-chemical study of chlorapatite and hydroxyapatite: From powders to plasma sprayed thin coatings. Biomed. Mater. 2012, 7, 054101.
  147. Navarrete-Segado, P.; Frances, C.; Tourbin, M.; Tenailleau, C.; Duployer, B.; Grossin, D. Powder bed selective laser process (sintering/melting) applied to tailored calcium phosphate-based powders. Addit. Manuf. 2021, 50, 102542.
  148. Ito, A.; Otsuka, Y.; Takeuchi, M.; Tanaka, H. Mechanochemical synthesis of chloroapatite and its characterization by powder X-ray diffractometory and attenuated total reflection-infrared spectroscopy. Colloid Polym. Sci. 2017, 295, 2011–2018.
  149. Merry, J.C.; Gibson, I.R.; Best, S.M.; Bonfield, W. Synthesis and characterization of carbonate hydroxyapatite. J. Mater. Sci. Mater. Med. 1998, 9, 779–783.
  150. Leilei, Z.; Hejun, L.; Kezhi, L.; Qiang, S.; Qiangang, F.; Yulei, Z.; Shoujie, L. Electrodeposition of carbonate-containing hydroxyapatite on carbon nanotubes/carbon fibers hybrid materials for tissue engineering application. Ceram. Int. 2015, 41, 4930–4935.
  151. Landi, E.; Celotti, G.; Logroscino, G.; Tampieri, A. Carbonated hydroxyapatite as bone substitute. J. Eur. Ceram. Soc. 2003, 23, 2931–2937.
  152. Ge, X.; Zhao, J.; Lu, X.; Li, Z.; Wang, K.; Ren, F.; Wang, M.; Wang, Q.; Qian, B. Controllable phase transformation of fluoridated calcium phosphate ultrathin coatings for biomedical applications. J. Alloys Compd. 2020, 847, 155920.
  153. Wang, J.; Chao, Y.; Wan, Q.; Zhu, Z.; Yu, H. Fluoridated hydroxyapatite coatings on titanium obtained by electrochemical deposition. Acta Biomater. 2009, 5, 1798–1807.
  154. Sun, J.; Wu, T.; Fan, Q.; Hu, Q.; Shi, B. Comparative study of hydroxyapatite, fluor-hydroxyapatite and Si-substituted hydroxyapatite nanoparticles on osteogenic, osteoclastic and antibacterial ability. RSC Adv. 2019, 9, 16106–16118.
  155. Wang, Y.; Wang, J.; Hao, H.; Cai, M.; Wang, S.; Ma, J.; Li, Y.; Mao, C.; Zhang, S. In Vitro and in Vivo Mechanism of Bone Tumor Inhibition by Selenium-Doped Bone Mineral Nanoparticles. ACS Nano 2016, 10, 9927–9937.
  156. Rodríguez-Valencia, C.; López-Álvarez, M.; Cochón-Cores, B.; Pereiro, I.; Serra, J.; González, P. Novel selenium-doped hydroxyapatite coatings for biomedical applications. J. Biomed. Mater. Res. Part A 2012, 101, 853–861.
  157. Tan, H.-W.; Mo, H.-J.; Lau, A.T.Y.; Xu, Y.-M. Selenium Species: Current Status and Potentials in Cancer Prevention and Therapy. Int. J. Mol. Sci. 2019, 20, 75.
  158. Casarrubios, L.; Gómez-Cerezo, N.; Sánchez-Salcedo, S.; Feito, M.; Serrano, M.; Saiz-Pardo, M.; Ortega, L.; de Pablo, D.; Díaz-Güemes, I.; Tomé, B.F.; et al. Silicon substituted hydroxyapatite/VEGF scaffolds stimulate bone regeneration in osteoporotic sheep. Acta Biomater. 2019, 101, 544–553.
  159. Aboudzadeh, N.; Dehghanian, C.; Shokrgozar, M.A. Effect of electrodeposition parameters and substrate on morphology of Si-HA coating. Surf. Coat. Technol. 2019, 375, 341–351.
  160. Dehghanian, C.; Aboudzadeh, N.; Shokrgozar, M.A. Characterization of silicon- substituted nano hydroxyapatite coating on magnesium alloy for biomaterial application. Mater. Chem. Phys. 2018, 203, 27–33.
  161. Graziani, G.; Boi, M.; Bianchi, M. A Review on Ionic Substitutions in Hydroxyapatite Thin Films: Towards Complete Biomimetism. Coatings 2018, 8, 269.
  162. Mumith, A.; Cheong, V.S.; Fromme, P.; Coathup, M.J.; Blunn, G.W. The effect of strontium and silicon substituted hydroxyapatite electrochemical coatings on bone ingrowth and osseointegration of selective laser sintered porous metal implants. PLoS ONE 2020, 15, e0227232.
  163. Robinson, L.; Salma-Ancane, K.; Stipniece, L.; Meenan, B.J.; Boyd, A.R. The deposition of strontium and zinc Co-substituted hydroxyapatite coatings. J. Mater. Sci. Mater. Med. 2017, 28, 51.
  164. Wolf-Brandstetter, C.; Beutner, R.; Hess, R.; Bierbaum, S.; Wagner, K.; Scharnweber, D.; Gbureck, U.; Moseke, C. Multifunctional calcium phosphate based coatings on titanium implants with integrated trace elements. Biomed. Mater. 2020, 15, 025006.
  165. Liu, S.-J.; Li, H.-J.; Zhang, L.-L.; Feng, L.; Yao, P. Strontium and magnesium substituted dicalcium phosphate dehydrate coating for carbon/carbon composites prepared by pulsed electrodeposition. Appl. Surf. Sci. 2015, 359, 288–292.
  166. Kolmas, J.; Groszyk, E.; Kwiatkowska-Różycka, D. Substituted Hydroxyapatites with Antibacterial Properties. BioMed Res. Int. 2014, 2014, 178123.
  167. Garbo, C.; Locs, J.; D’Este, M.; Demazeau, G.; Mocanu, A.; Roman, C.; Horovitz, O.; Tomoaia-Cotisel, M. Advanced Mg, Zn, Sr, Si Multi-Substituted Hydroxyapatites for Bone Regeneration. Int. J. Nanomed. 2020, 15, 1037–1058.
  168. Bracci, B.; Torricelli, P.; Panzavolta, S.; Boanini, E.; Giardino, R.; Bigi, A. Effect of Mg2+, Sr2+, and Mn2+ on the chemico-physical and in vitro biological properties of calcium phosphate biomimetic coatings. J. Inorg. Biochem. 2009, 103, 1666–1674.
  169. Furko, M.; Jiang, Y.; Wilkins, T.; Balázsi, C. Electrochemical and morphological investigation of silver and zinc modified calcium phosphate bioceramic coatings on metallic implant materials. Mater. Sci. Eng. C 2016, 62, 249–259.
  170. Furko, M.; May, Z.; Havasi, V.; Kónya, Z.; Grünewald, A.; Detsch, R.; Boccaccini, A.R.; Balázsi, C. Pulse electrodeposition and characterization of non-continuous, multi-element-doped hydroxyapatite bioceramic coatings. J. Solid State Electrochem. 2017, 22, 555–566.
  171. Furko, M.; Della Bella, E.; Fini, M.; Balázsi, C. Corrosion and biocompatibility examination of multi-element modified calcium phosphate bioceramic layers. Mater. Sci. Eng. C 2019, 95, 381–388.
  172. Huang, Y.; Ding, Q.; Pang, X.; Han, S.; Yan, Y. Corrosion behavior and biocompatibility of strontium and fluorine co-doped electrodeposited hydroxyapatite coatings. Appl. Surf. Sci. 2013, 282, 456–462.
  173. Bir, F.; Khireddine, H.; Mekhalif, Z.; Bonnamy, S. Pulsed electrodeposition of Ag+ doped prosthetic Fluorohydroxyapatite coatings on stainless steel substrates. Mater. Sci. Eng. C 2020, 118, 111325.
  174. Vo, T.H.; Le, T.D.; Pham, T.N.; Nguyen, T.T.; Nguyen, T.P.; Dinh, T.M.T. Electrodeposition and characterization of hydroxyapatite coatings doped by Sr2+, Mg2+, Na+ and F− on 316L stainless steel. Adv. Nat. Sci. Nanosci. Nanotechnol. 2018, 9, 045001.
  175. Chambard, M.; Remache, D.; Balcaen, Y.; Dalverny, O.; Alexis, J.; Siadous, R.; Bareille, R.; Catros, S.; Fort, P.; Grossin, D.; et al. Effect of silver and strontium incorporation route on hydroxyapatite coatings elaborated by rf-SPS. Materialia 2020, 12, 100809.
More
© Text is available under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/)
Video Production Service
Feedback